The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
Mutations in p53 are almost synonymous with cancer – be it susceptibility to the disease or response to treatment – and therefore, are a critical determinant of overall survival. As most of these mutations occur in the DNA-binding domain of p53, many of the clinical correlations with mutant p53 have...
Main Author: | Sabapathy, Kanaga |
---|---|
Format: | Online |
Language: | English |
Published: |
Frontiers Media S.A.
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674554/ |
Similar Items
-
Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53
by: Vikhanskaya, Faina, et al.
Published: (2007) -
Targeting Oncogenic Mutant p53 for Cancer Therapy
by: Parrales, Alejandro, et al.
Published: (2015) -
Mutant p53 exerts oncogenic functions by modulating cancer cell metabolism
by: Zhou, Ge, et al.
Published: (2014) -
p73: a Positive or Negative Regulator of Angiogenesis, or Both?
by: Sabapathy, Kanaga
Published: (2016) -
Wiring the oncogenic circuitry: Pin1 unleashes mutant p53
by: Napoli, Marco, et al.
Published: (2011)